Evidence map›Paper›PMID 40289757›Full record

SynthesisActa dermato-venereologica2025

Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation.

Alexandra Junge, Susanne Radonjic-Hoesli, Simon Bossart, Dagmar Simon, Pierre De Viragh, Robert E Hunger, Kristine Heidemeyer, S Morteza Seyed Jafari

Abstract readSystematic Review
In one paragraph

Synthesis in Acta dermato-venereologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexandra JungeDepartment of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.
Susanne Radonjic-HoesliDepartment of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.
Simon BossartDepartment of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.
Dagmar SimonDepartment of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.
Pierre De ViraghDepartment of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.
Robert E HungerDepartment of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.
Kristine HeidemeyerDepartment of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.
S Morteza Seyed JafariDepartment of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland. morteza.jafari@insel.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Topical minoxidil is the mainstay of treatment for androgenic alopecia and is also used off-label for other forms of hair loss. Despite its efficacy and favourable safety profile, the use of minoxidil is associated with various side effects, the most commonly reported of which is contact dermatitis. A clear distinction between allergic contact dermatitis and irritant contact dermatitis to minoxidil is critical for management of androgenic alopecia. This article presents a systematic review of the current literature, evaluating minoxidil-induced allergic contact dermatitis. Of the 251 records identified through the database search, a total of 21 studies were included in the review. Most patients presented with classic signs of contact dermatitis, including erythema, pruritus, and increased scaling of the scalp. Of the patients with positive patch tests, a total of 54 patients showed sensitization to minoxidil itself and 12 patients to vehicle components. Patients with suspected signs of contact dermatitis such as erythema, scaling, and pruritus after minoxidil application should undergo patch testing to confirm or exclude allergy. For the test, the differential reactivity of minoxidil in various vehicles should be considered. Patients who are sensitive to propylene glycol should be offered alternative minoxidil formulations.

Indexed as

AlopeciaDermatitis, Allergic ContactDermatitis, IrritantMinoxidilAdministration, CutaneousAdministration, TopicalHumansMalePatch TestsRisk FactorsMinoxidil

Identifiers

PMID40289757
PMCPMC12053519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.